UPDATE : Tuesday, October 23, 2018
상단여백
GC MS breaks ground for new local plant
GC MS, previously known as Green Cross MS, announced Wednesday that constru...
by Lee Han-soo  |  2018-09-12 14:58
라인
‘Regulator’s scrutiny into ToolGen’s patent issue might discourage biotech research’
The biotech industry is paying close attention to how the recent controvers...
by So Jae-hyeon  |  2018-09-12 14:25
라인
‘Xgeva reduces risk of bone problems in solid tumor patients’
Amgen Korea’s Xgeva (ingredient: denosumab), a therapy for bone metastases ...
by Nam Doo-hyun  |  2018-09-12 12:23
라인
ABL Bio, Yuhan sign cooperative agreement
ABL Bio said Monday that it has signed a license-out and cooperative agreem...
by Lee Han-soo  |  2018-09-11 16:54
라인
Shire’s SBS treatment to bring new hope to pediatric patients
Gattex (ingredient name: Teduglutide), Shire’s short bowel syndrome (SBS) t...
by Lee Han-soo  |  2018-09-11 16:17
라인
Hepatitis C patients wait for Maviret’s arrival
Korean physicians and patients have expressed high expectations for AbbVie ...
by Nam Doo-hyun  |  2018-09-11 16:16
라인
Korean hospitals no more vulnerable to MERS
Korean hospitals have entered into a high alert mode as the authorities rec...
by Song Soo-youn  |  2018-09-11 14:06
라인
Medpecto to test immunotherapy combo with MSD
Medpacto, a subsidiary of Theragen ETEX, said Tuesday that the Ministry of ...
by Lee Han-soo  |  2018-09-11 13:04
라인
Wonkwang University Hospital to continue cooperation with US army
Wonkwang University Hospital (WUH) and the Eighth U.S. Army (EUSA) in Gunsa...
by Lee Han-soo  |  2018-09-11 10:54
라인
Astellas wins nod for phase-3 trial on gastric cancer treatment
Astellas has obtained the regulatory approval to go ahead with a global pha...
by Lee Hye-seon  |  2018-09-11 10:38
라인
MERS infection affects stock market
Pharmaceuticals and biotech businesses are gathering renewed attention afte...
by So Jae-hyeon  |  2018-09-10 16:25
라인
Doctors call for tighter quarantine control over MERS case
Korea’s medical community urged the government to prepare measures to fix t...
by Choi Gwang-seok  |  2018-09-10 15:40
라인
‘ToolGen’s KOSDAQ listing might be in peril’
ToolGen, a local biotech firm specialized in gene editing, has been mired i...
by Nam Doo-hyun  |  2018-09-10 14:59
라인
Major hospitals successfully contain Korea’s 1st MERS case in 3 years
The so-called big-five hospitals have successfully managed to contain the M...
by Lee Han-soo  |  2018-09-10 14:25
라인
Kwangdong licenses Canadian company’s nonsteroidal anti-inflammatory drug candidate
Kwangdong Pharmaceutical said Monday that it has signed a licensing agreeme...
by Lee Han-soo  |  2018-09-10 14:23
라인
MERS fear haunts Korea again
The Korean health authorities have confirmed the first case of Middle East ...
by Kwak Sung-sun  |  2018-09-10 14:12
라인
Seoul forced to toughen rules to end ‘healthcare dine and dash' by expats
In May 2015, a Mongolian came to Korea and gained access to health insuranc...
by Lee Han-soo  |  2018-09-07 18:17
라인
Pfizer Korea ordered to suspend imports of 3 drugs for poor quality control
The government has ordered Pfizer Korea to halt imports of three drugs for ...
by Lee Hye-seon  |  2018-09-07 16:24
라인
‘AI will not solve all the problems in the medical sector’
The Korean medical community is seeking to combine artificial intelligence ...
by Lee Han-soo  |  2018-09-07 16:23
라인
Is inter-Korean health community feasible?
A South Korean medical expert claimed that two Koreas should cooperate to f...
by Kwak Sung-sun  |  2018-09-07 16:21
-12345678910-
Anticoagulant Lixiana outpaces Eliquis in Q3 prescriptionsAnticoagulant Lixiana outpaces Eliquis in Q3 prescriptions
여백
Most viewed
여백
Opinion
[Column]‘Doctors made patients want to bring CCTVs in operating rooms’
[Column]‘Doctors made patients want to bring CCTVs in operating rooms’
[Column] Pyongyang summit prelude for inter-Korean health community
[Column] Pyongyang summit prelude for inter-Korean health community
[Column] What makes telemedicine controversial?
[Column] What makes telemedicine controversial?
여백
Back to Top